CT-322

· Adnexus, a Bristol-Myers Squibb R&D Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CT-322, covering 2009-02-24 to 2010-10-27. Get the full timeline:

Most recent: Clinical Trial Update: CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme [Phase 1]

See pricing